Works matching IS 09395555 AND DT 2020 AND VI 99 AND IP 12


Results: 33
    1
    2
    3
    4
    5
    6
    7

    Effect of allogeneic HCT from unrelated donors in AML patients with intermediate- or poor-risk cytogenetics: a retrospective study from the Japanese Society for HCT.

    Published in:
    Annals of Hematology, 2020, v. 99, n. 12, p. 2927, doi. 10.1007/s00277-020-04261-6
    By:
    • Yamasaki, Satoshi;
    • Mori, Jinichi;
    • Kanda, Junya;
    • Imahashi, Nobuhiko;
    • Uchida, Naoyuki;
    • Doki, Noriko;
    • Tanaka, Masatsugu;
    • Katayama, Yuta;
    • Eto, Tetsuya;
    • Ozawa, Yukiyasu;
    • Takada, Satoru;
    • Onizuka, Makoto;
    • Hino, Masayuki;
    • Kanda, Yoshinobu;
    • Fukuda, Takahiro;
    • Atsuta, Yoshiko;
    • Yanada, Masamitsu
    Publication type:
    Article
    8

    Prognostic value of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in multiple myeloma patients treated with thalidomide-based regimen.

    Published in:
    Annals of Hematology, 2020, v. 99, n. 12, p. 2881, doi. 10.1007/s00277-020-04092-5
    By:
    • Szudy-Szczyrek, Aneta;
    • Mlak, Radosław;
    • Mielnik, Michał;
    • Szczyrek, Michał;
    • Nowaczyńska, Aleksandra;
    • Homa-Mlak, Iwona;
    • Zmorzyński, Szymon;
    • Kuśmierczuk, Kinga;
    • Sompor, Jacek;
    • Filip, Agata;
    • Małecka-Massalska, Teresa;
    • Hus, Marek
    Publication type:
    Article
    9
    10
    11
    13

    Factors that predict delayed platelet recovery after autologous stem cell transplantation for lymphoma or myeloma.

    Published in:
    Annals of Hematology, 2020, v. 99, n. 12, p. 2893, doi. 10.1007/s00277-020-04112-4
    By:
    • Nagayama, Takashi;
    • Ashizawa, Masahiro;
    • Ikeda, Takashi;
    • Kawaguchi, Shin-ichiro;
    • Toda, Yumiko;
    • Ito, Shoko;
    • Ochi, Shin-ichi;
    • Mashima, Kiyomi;
    • Umino, Kento;
    • Minakata, Daisuke;
    • Nakano, Hirofumi;
    • Yamasaki, Ryoko;
    • Morita, Kaoru;
    • Kawasaki, Yasufumi;
    • Yamamoto, Chihiro;
    • Fujiwara, Shin-ichiro;
    • Hatano, Kaoru;
    • Sato, Kazuya;
    • Oh, Iekuni;
    • Ohmine, Ken
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Predictors of early death, serious hemorrhage, and differentiation syndrome in Japanese patients with acute promyelocytic leukemia.

    Published in:
    Annals of Hematology, 2020, v. 99, n. 12, p. 2787, doi. 10.1007/s00277-020-04245-6
    By:
    • Minamiguchi, Hitoshi;
    • Fujita, Hiroyuki;
    • Atsuta, Yoshiko;
    • Asou, Norio;
    • Sakura, Toru;
    • Ueda, Yasunori;
    • Sawa, Masashi;
    • Dobashi, Nobuaki;
    • Taniguchi, Yasuhiro;
    • Suzuki, Rikio;
    • Uchino, Yoshihito;
    • Tomita, Akihiro;
    • Tamaki, Shigehisa;
    • Hagihara, Maki;
    • Fujimaki, Katsumichi;
    • Yanada, Masamitsu;
    • Maeda, Yoshinobu;
    • Iwanaga, Masako;
    • Usui, Noriko;
    • Kobayashi, Yukio
    Publication type:
    Article
    23
    24
    25
    26
    27

    First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A—results of a retrospective analysis.

    Published in:
    Annals of Hematology, 2020, v. 99, n. 12, p. 2821, doi. 10.1007/s00277-020-04171-7
    By:
    • Pouyiourou, M.;
    • Meyer, A.;
    • Stroux, A.;
    • Viardot, A.;
    • La Rosée, P.;
    • Maschmeyer, G.;
    • Kämpfe, D.;
    • Kahl, C.;
    • Vucinic, V.;
    • Monecke, A.;
    • Hirt, C.;
    • Weber, T.;
    • Meissner, J.;
    • Witzens-Harig, M.;
    • Böttcher, S.;
    • Schmalenberg, H.;
    • Marks, R.;
    • Prange-Krex, G.;
    • Kroschinsky, F.;
    • Hauf, E.
    Publication type:
    Article
    28
    29
    30

    KRD (carfilzomib and lenalidomide plus dexamethasone) for the treatment of relapsed or refractory multiple myeloma in the real-life: a retrospective survey in 123 patients.

    Published in:
    Annals of Hematology, 2020, v. 99, n. 12, p. 2903, doi. 10.1007/s00277-020-04158-4
    By:
    • Palmieri, Salvatore;
    • Rocco, S.;
    • Vitagliano, O.;
    • Catalano, L.;
    • Cerchione, C.;
    • Vincelli, I. D.;
    • Scopelliti, A.;
    • Gentile, M.;
    • Farina, G.;
    • Barone, M.;
    • Gagliardi, A.;
    • Esposito, D.;
    • Arcamone, M.;
    • Amico, V.;
    • Fontana, R.;
    • Sementa, A.;
    • Sica, A.;
    • Svanera, G.;
    • Pane, F.;
    • Ferrara, F.
    Publication type:
    Article
    31
    32
    33

    Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphoma.

    Published in:
    Annals of Hematology, 2020, v. 99, n. 12, p. 2837, doi. 10.1007/s00277-020-04021-6
    By:
    • Davies, Andrew;
    • Trask, Peter;
    • Demeter, Judit;
    • Florschütz, Axel;
    • Hänel, Mathias;
    • Kinoshita, Tomohiro;
    • Pettengell, Ruth;
    • Quach, Hang;
    • Robinson, Stephen;
    • Sadullah, Shalal;
    • Sancho, Juan-Manuel;
    • Udvardy, Miklos;
    • Witzens-Harig, Mathias;
    • Knapp, Andrea;
    • Liu, Wenxin
    Publication type:
    Article